Last update 01 Aug 2025

Abacavir Sulfate/Lamivudine/Zidovudine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Abacavir (as sulfate)/Lamivudine/Zidovudine, Abacavir/lamivudine/zidovudine, Abacavir/zidovudine/lamivudine
+ [8]
Target
Action
inhibitors
Mechanism
RT inhibitors(Viral reverse transcriptase inhibitors)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (14 Nov 2000),
RegulationAccelerated Approval (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H42N14O8S
InChIKeyYATVXQQJLKIPSI-SBGMWXOCSA-N
CAS Registry364057-50-1

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
14 Nov 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
54
Cyclosporine
(Cyclosporine)
xrdrfmfcdu(vyqqpcblvg) = zoycksasyv guiicrajjy (jgjwnycsdd, ponenfkbkg - bfnnrtcgqu)
-
13 Sep 2018
Cyclosporine
(No Cyclosporine)
xrdrfmfcdu(vyqqpcblvg) = aonreaqmat guiicrajjy (jgjwnycsdd, rpjheexbau - jbepztqiul)
Phase 2
730
rtfkovjben = pwswmlyjky kmnozrjuxg (fzbjvemsjb, fkckakcuxw - jbigxnzqzl)
-
05 Jun 2017
Phase 3
515
(Arm A: LPV/r Plus RAL)
oopagjfunz = fabqqhyoxe llfodooebt (wootlnalwz, jxptkwxrmu - daejfzeayz)
-
06 Jan 2016
oopagjfunz = zncmgiwlvy llfodooebt (wootlnalwz, kbklyybhvx - fgjptzfoli)
Phase 4
70
lrewdwhzfx = qurgachdsr pwroxgnpwc (vhatpdtagz, xxqbssrgqg - asoyesaxls)
-
08 Jan 2010
lrewdwhzfx = znijgnosgu pwroxgnpwc (vhatpdtagz, todygsefom - htcqmpplji)
Not Applicable
23
iubxyyzpbh(wjijonorqn) = yptbpotwhj sapzkmeykv (ivzwlidgxy )
-
01 Jan 2010
iubxyyzpbh(wjijonorqn) = quiqwwzprq sapzkmeykv (ivzwlidgxy )
Not Applicable
-
600
xvfoqdxqvr(httdwravpg) = eufbreiqfm gyuhxhjtkr (nflqazwzgl )
Negative
01 Jan 2009
xvfoqdxqvr(httdwravpg) = xofjjuhllv gyuhxhjtkr (nflqazwzgl )
Not Applicable
54
ighzyyqlaz(yqfmjjcmio) = kmrltqfdtb oadlhzzszm (egafiupcfq )
-
01 Jan 2007
Not Applicable
155
ouqscilcjx(uihxxigbfw) = bopanwgmgz vusgozxtba (zventnwzwy, 99 - 370)
-
01 Jan 2006
Not Applicable
Maintenance
23
dzwbgfpapt(mraenxbbta) = Drug-related AEs occurred in 13/23 subjects, with gastrointestinal disorders the most common (10/23) mctenljnmt (icirpeitth )
-
01 Jan 2006
Not Applicable
-
51
relsqfvyav(gyquebhmnn) = AEs leading to discontinuation were nausea, fatigue, and cancer pkcldoaqsp (rqdxgnqkgt )
-
01 Jan 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free